Silk fibroin nanoparticles prepared by electrospray as controlled release carriers of cisplatin

Materials Science and Engineering C

Volumn 44, Issue , 2014, Pages 166-174

  Qu, Jing ^a   Liu, Yu ^a   Yu, Yanni ^a   Li, Jing ^a   Luo, Jingwan ^a   Li, Mingzhong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Cisplatin; Electrospray; Nanoparticle; Silk fibroin

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; CELL DEATH; CYTOTOXICITY; DISEASES; NANOPARTICLES; PLATINUM COMPOUNDS; TUMORS;

ANTI-TUMOR ACTIVITIES; CIS-PLATIN; CONTROLLED RELEASE; COORDINATION BONDS; ELECTROSPRAYS; GROWTH INHIBITION; LUNG CANCER CELLS; SILK FIBROIN;

METAL NANOPARTICLES; NANOPARTICLES;

ANTINEOPLASTIC AGENT; CISPLATIN; DELAYED RELEASE FORMULATION; DRUG CARRIER; FIBROIN; NANOPARTICLE;

ANIMAL; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; MOUSE; PHARMACOLOGY; PROCEDURES; TOXICITY TESTING; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBROINS; HUMANS; MICE; NANOPARTICLES; TOXICITY TESTS;

EID: 84906558504     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2014.08.034     Document Type: Article

References (29)

1. S.S. Kakar, V.R. Jala, and M.Y. Fong Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines Biochem. Biophys. Res. Commun. 423 2012 819 825 10.1016/j.bbrc.2012.06.047
2. E.E. El-Awady, Y.M. Moustafa, D.M. Abo-Elmatty, and A. Radwan Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies Eur. J. Pharmacol. 650 2011 335 341 10.1016/j.ejphar.2010.09.085
3. J.H. Kim, Y.S. Kim, K. Park, S. Lee, H.Y. Nam, K.H. Min, H.G. Jo, J.H. Park, K. Choi, S.Y. Jeong, R.W. Park, I.S. Kim, K. Kim, and I.C. Kwon Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice J. Controlled Release 127 2008 41 49 10.1016/j.jconrel.2007.12.014
4. D. Ding, Z.S. Zhu, Q. Liu, J. Wang, Y. Hu, X.Q. Jiang, and B.R. Liu Cisplatin-loaded gelatin-poly (acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors Eur. J. Pharm. Biopharm. 79 2011 142 149 10.1016/j.ejpb.2011.01.008
5. X.L. Li, R.T. Li, X.P. Qian, Y.T. Ding, Y.X. Tu, R. Guo, Y. Hu, X.Q. Jiang, W.H. Guo, and B.R. Liu Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate Eur. J. Pharm. Biopharm. 70 2008 726 734 10.1016/j.ejpb.2008.06.016
6. C.L. Tseng, W.Y. Su, K.C. Yen, K.C. Yang, and F.H. Lin The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation Biomaterials 30 2009 3476 3485 10.1016/j.biomaterials.2009.03.010
7. D. Moreno, S. Zalba, I. Navarro, C.T. de Ilarduya, and M.J. Garrido Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice Eur. J. Pharm. Biopharm. 74 2010 265 274 10.1016/j.ejpb.2009. 10.005
8. S. Khoee, A. Sattari, and F. Atyabi Physico-chemical properties investigation of cisplatin loaded polybutyladipate (PBA) nanoparticles prepared by w/o/w Mater. Sci. Eng. C 32 2012 1078 1086 10.1016/j.msec.2011.09.005
9. D.Z. Chen, Q.S. Tang, W.Q. Xue, J.Y. Xiang, L. Zhang, and X.R. Wang The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles J. Biomed. Res. 24 2010 26 32 10.1016/S1674-8301(10)60005-X
10. Y.F. Wang, P.F. Liu, L.H. Qiu, Y. Sun, M.J. Zhu, L.Y. Gu, W. Di, and Y.R. Duan Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice Biomaterials 34 2013 4068 4077 10.1016/j.biomaterials.2012.12.033
11. G. Mattheolabakis, E. Taoufik, S. Haralambous, M.L. Roberts, and K. Avgoustakis In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles Eur. J. Pharm. Biopharm. 71 2009 190 195 10.1016/j.ejpb.2008.09.011
12. F.P. Seib, M. Herklotz, K.A. Burke, M.F. Maitz, C. Werner, and D.L. Kaplan Multifunctional silk-heparin biomaterials for vascular tissue engineering applications Biomaterials 35 2014 83 91 10.1016/j.biomaterials.2013.09.053
13. S.Q. Yan, Q. Zhang, J.N. Wang, Y. Liu, S.Z. Lu, M.Z. Li, and D.L. Kaplan Silk fibroin/chondroitin sulfate/hyaluronic acid ternary scaffolds for dermal tissue reconstruction Acta Biomater. 9 2013 6771 6782 10.1016/j.actbio.2013.02. 016
14. P.G. Shi, T.S.K. Teh, S.L. Toh, and J.C.H. Goh Variation of the effect of calcium phosphate enhancement of implanted silk fibroin ligament bone integration Biomaterials 34 2013 5947 5957 10.1016/j.biomaterials.2013.04.046
15. W. Zhang, J.L. Chen, J.D. Tao, C.C. Hu, L.K. Chen, H.S. Zhao, G.W. Xu, B.C. Heng, and H.W. Ouyang The promotion of osteochondral repair by combined intra-articular injection of parathyroid hormone-related protein and implantation of a bi-layer collagen-silk scaffold Biomaterials 34 2013 6046 6057 10.1016/j.biomaterials.2013.04.055
16. Y. Gu, J.B. Zhu, C.B. Xue, Z.M.Y. Li, F. Ding, Y.M. Yang, and X.S. Gu Chitosan/silk fibroin-based, Schwann cell-derived extracellular matrix-modified scaffolds for bridging rat sciatic nerve gaps Biomaterials 35 2014 2253 2263 10.1016/j.biomaterials.2013.11.087
17. R.L. Horan, K. Antle, A.L. Collette, Y.Z. Wang, J. Huang, J.E. Moreau, V. Volloch, D.L. Kaplan, and G.H. Altman In vitro degradation of silk fibroin Biomaterials 26 2005 3385 3393 10.1016/j.biomaterials.2004.09.020 (Pubitemid 40038134)
18. M.Y. Li, Y. Zhao, T. Tong, X.H. Hou, B.S. Fang, S.Q. Wu, X.Y. Shen, and H. Tong Study of the degradation mechanism of Chinese historic silk (Bombyx mori) for the purpose of conservation Polym. Degrad. Stab. 98 2013 727 735 10.1016/j.polymdegradstab.2012.12.021
19. R.C. You, Y. Zhang, Y. Liu, G.Y. Liu, and M.Z. Li The degradation behavior of silk fibroin derived from different ionic liquid solvents Nat. Sci. 5 2013 10 19 10.4236/ns.2013.56A002
20. J. Qu, L. Wang, Y.P. Hu, L.S. Wang, R.C. You, and M.Z. Li Preparation of silk fibroin microspheres and its cytocompatibility J. Biomater. Nanobiotechnol. 4 2013 84 90 10.4236/jbnb.2013.41011
21. 2-C electrocatalyst prepared by microwave-assisted ethylene glycol process Appl. Catal. B Environ. 102 2011 9 18 10.1016/j.apcatb.2010.11.018
22. R.P.A. Hartman, D.J. Brunner, D.M.A. Camelot, J.C.M. Marijnissen, and B. Scarlett Jet break-up in electrohydrodynamic atomization in the cone-jet mode J. Aerosol Sci. 31 2000 65 95 10.1016/S0021-8502(99)00034-8
23. X.L. Yan, and R.A. Gemeinhart Cisplatin delivery from poly (acrylic acid-co-methyl methacrylate) microparticles J. Controlled Release 106 2005 198 208 10.1016/j.jconrel.2005.05.005 (Pubitemid 41149078)
24. E. Pretsch, P. Buhlmann, and C. Affolter IR spectroscopy Structure Determination of Organic Compounds: Tables of Spectral Data 2000 Springer-Verlag Berlin 261 (291)
25. Z.F. Wang, M. Shi, J.H. Li, and Z. Zheng Influence of moderate pre-oxidation treatment on the physical, chemical and phosphate adsorption properties of iron-containing activated carbon J. Environ. Sci. 26 2014 519 528 10.1016/S1001-0742(13)60440-4
26. H.F. Ye, J. Li, R.Z. Hu, Z.F. Yi, J. Li, Y.L. Wu, X.G. Xi, and Z.R. Wu Poly(γ,l-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice Biomaterials 27 2006 5958 5965 10.1016/j.biomaterials.2006.08.016 (Pubitemid 44332519)
27. N. Nishiyama, S. Okazaki, H. Cabral, M. Miyamoto, Y. Kato, Y. Sugiyama, K. Nishio, Y. Matsumura, and K. Kataoka Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice Cancer Res. 63 2003 8977 8983 (http://cancerres.aacrjournals.org/content/63/24/8977) (Pubitemid 38064079)
28. H. Holback, and Y. Yeo Intratumoral drug delivery with nanoparticulate carriers Pharm. Res. 28 2011 1819 1830 10.1007/s11095-010-0360-y
29. S. Torosean, B. Flynn, J. Axelsson, J. Gunn, K.S. Samkoe, T. Hasan, M.M. Doyley, and B.W. Pogue Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure Nanomed. Nanotechnol. Biol. Med. 9 2013 151 158 10.1016/j.nano.2012.07.002